{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T22:34:34Z","timestamp":1788561274458,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T00:00:00Z","timestamp":1624060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T00:00:00Z","timestamp":1624060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Allergy Asthma Clin Immunol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Allergic rhinitis (AR) is one of the most widespread immune conditions worldwide. However, common treatments often present with significant side effects or are cost-prohibitive for much of the population. A plethora of treatments have been used for the treatment of AR including antihistamines, steroids, and immune modulators. Among the treatments which have shown potential for efficacy in treating AR with a minimum of side effects but remains understudied is the conditionally essential amino acid taurine. Taurine has been previously shown to reduce AR symptoms. Here, we examine the role of taurine in modulating T regulatory cells, modulating the cytokine response in AR, and restoring healthy nasal mucosa.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Blood samples from 20 healthy donors and 20 AR patients were compared for CD4<jats:sup>+<\/jats:sup>CD25<jats:sup>+<\/jats:sup>FoxP3<jats:sup>+<\/jats:sup> T regulatory (Treg) cell population percentage, cytokine release, and STAT1 signaling with and without taurine treatment or IL-35 neutralization. An OVA-induced AR mouse model was administered vehicle, taurine, or taurine plus an IL-35 neutralizing antibody and assayed for sneezing frequency, inflammatory cytokine response, nasal mucosa goblet cell density, and T regulatory cell percentage. CD4<jats:sup>+<\/jats:sup> cells were further examined for cytokine release, STAT1 phosphorylation, and response to an anti-IL-35 antibody with and without a STAT1 inhibitor.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Comparison of blood from normal donors and AR patients showed a reduction in CD4<jats:sup>+<\/jats:sup>CD25<jats:sup>+<\/jats:sup>FoxP3<jats:sup>+<\/jats:sup> Treg cells in AR patients and a strong correlation between Treg percentage and IL-35 release. A similar pattern of Treg suppression was found in untreated AR mice when compared to normal control mice wherein there was a reduction in Treg percentage and a corresponding decrease in IL-35 release. AR mice also demonstrated increased sneezing frequency, an infiltration of goblet cell in nasal mucosa, and a reduction in IL-35 release from CD4<jats:sup>+<\/jats:sup> cells. Conversely, IL-4, IL-5, and IL-13 secretion from CD4<jats:sup>+<\/jats:sup> cells were increased in AR model mice, as was STAT1 phosphorylation. When AR mice were treated with taurine, sneezing frequency and nasal mucosa goblet cell content were reduced while Treg abundance was increased to that of normal mice. Accordingly, IL-35 release was restored, while IL-4, IL-5, and IL-13 secretion from CD4<jats:sup>+<\/jats:sup> cells were suppressed. Likewise, STAT1 phosphorylation was inhibited with taurine treatment. Taurine-treated mice also given an IL-35 neutralizing antibody exhibited AR pathology including frequent sneezing and high nasal goblet cell content while retaining a restoration of Tregs. Furthermore, murine AR model CD4<jats:sup>+<\/jats:sup> cells exposed to recombinant IL-35 responded with a reduction in inflammatory cytokine release and a decrease in STAT1 phosphorylation, mimicking the effect of taurine treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Taurine induces release of IL-35 in AR; IL-35 promotes the production of CD4<jats:sup>+<\/jats:sup>CD25<jats:sup>+<\/jats:sup>FoxP3<jats:sup>+<\/jats:sup> Treg cells via a STAT1-dependent pathway. The restoration of Treg populations by taurine normalizes the inflammatory response, reduces AR symptomology, and reduces histopathologic signs of AR.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13223-021-00562-1","type":"journal-article","created":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T11:03:43Z","timestamp":1624100623000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Taurine promotes the production of CD4+CD25+FOXP3+ Treg cells through regulating IL-35\/STAT1 pathway in a mouse allergic rhinitis model"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8644-9439","authenticated-orcid":false,"given":"Jing","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhai","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,19]]},"reference":[{"key":"562_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1398-9995.2007.01620.x","volume":"63","author":"J Bousquet","year":"2008","unstructured":"Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, Zuberbier T, Baena-Cagnani CE, Canonica GW, Van Weel C, Agache I, A\u00eft-Khaled N, et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN and AllerGen). Allergy Eur J Allergy Clin Immunol. 2008;63:8\u2013160.","journal-title":"Allergy Eur J Allergy Clin Immunol"},{"key":"562_CR2","volume-title":"Pediatric otolaryngology","author":"CD Bluestone","year":"2003","unstructured":"Bluestone CD. Pediatric otolaryngology. Houston: Gulf Professional Publishing; 2003."},{"key":"562_CR3","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1056\/NEJMcp1412282","volume":"372","author":"LM Wheatley","year":"2015","unstructured":"Wheatley LM, Togias A. Allergic rhinitis. N Engl J Med. 2015;372:456\u201363. https:\/\/doi.org\/10.1056\/NEJMcp1412282.","journal-title":"N Engl J Med"},{"key":"562_CR4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2500\/105065800781329582","volume":"14","author":"R Pawankar","year":"2000","unstructured":"Pawankar R, Yamagishi S, Yagi T. Revisiting the roles of mast cells in allergic rhinitis and its relation to local IgE synthesis. Am J Rhinol. 2000;14:309\u201317.","journal-title":"Am J Rhinol"},{"key":"562_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1248\/bpb.b18-01021","volume":"43","author":"O Kaminuma","year":"2020","unstructured":"Kaminuma O, Nishimura T, Saeki M, Mori A, Hiroi T. T cell-mediated nasal hyperresponsiveness in allergic rhinitis. Biol Pharm Bull. 2020;43:36\u201340.","journal-title":"Biol Pharm Bull"},{"key":"562_CR6","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/j.1348-0421.2012.00449.x","volume":"56","author":"M Hirano","year":"2012","unstructured":"Hirano M, Ogita-Nakanishi H, Miyachi W, Hannya N, Yamamoto-Kimoto Y, Sakurai K, Miyoshi-Higashino M, Tashiro-Yamaji J, Kato R, Ijiri Y, Tanaka K, Kanazawa A, et al. Essential role of macrophages in the initiation of allergic rhinitis in mice sensitized intranasally once with cedar pollen: regulation of class switching of immunoglobulin in B cells by controlling interleukin-4 production in T cells of submandibular lymph nodes. Microbiol Immunol. 2012;56:392\u2013405.","journal-title":"Microbiol Immunol"},{"key":"562_CR7","doi-asserted-by":"publisher","first-page":"236","DOI":"10.4168\/aair.2018.10.3.236","volume":"10","author":"J Luo","year":"2018","unstructured":"Luo J, Guo H, Liu Z, Peng T, Hu X, Han M, Yang X, Zhou X, Li H. Analysis of peripheral B cell subsets in patients with allergic rhinitis. Allergy Asthma Immunol Res. 2018;10:236\u201343.","journal-title":"Allergy Asthma Immunol Res"},{"key":"562_CR8","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1111\/cea.12780","volume":"46","author":"AO Eifan","year":"2016","unstructured":"Eifan AO, Durham SR. Pathogenesis of rhinitis. Clin Exp Allergy. 2016;46:1139\u201351. https:\/\/doi.org\/10.1111\/cea.12780.","journal-title":"Clin Exp Allergy"},{"key":"562_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13223-015-0093-x","volume":"11","author":"K K\u00f6nig","year":"2015","unstructured":"K\u00f6nig K, Klemens C, Eder K, San Nicol\u00f3 M, Becker S, Kramer MF, Gr\u00f6ger M. Cytokine profiles in nasal fluid of patients with seasonal or persistent allergic rhinitis. Allergy Asthma Clin Immunol. 2015;11:26.","journal-title":"Allergy Asthma Clin Immunol"},{"key":"562_CR10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3390\/ijms20010213","volume":"20","author":"H Kawauchi","year":"2019","unstructured":"Kawauchi H, Yanai K, Wang DY, Itahashi K, Okubo K. Antihistamines for allergic rhinitis treatment from the viewpoint of nonsedative properties. Int J Mol Sci. 2019;20:213.","journal-title":"Int J Mol Sci"},{"key":"562_CR11","first-page":"985","volume":"92","author":"DKC Sur","year":"2015","unstructured":"Sur DKC, Plesa ML. Treatment of allergic rhinitis. Am Fam Phys. 2015;92:985\u201392.","journal-title":"Am Fam Phys"},{"key":"562_CR12","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/0091-6749(92)90125-L","volume":"90","author":"JW Georgitis","year":"1992","unstructured":"Georgitis JW. The anticholinergic treatment of allergic perennial rhinitis. J Allergy Clin Immunol. 1992;90:1071\u20136.","journal-title":"J Allergy Clin Immunol"},{"key":"562_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2174\/187152308783769177","volume":"7","author":"I Can","year":"2008","unstructured":"Can I, Samim E. Mast cell stabilizers in the treatment of allergic rhinitis. Antiinflamm Antiallergy Agents Med Chem. 2008;7:9\u201315.","journal-title":"Antiinflamm Antiallergy Agents Med Chem"},{"key":"562_CR14","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s11882-002-0025-y","volume":"2","author":"SM Parnes","year":"2002","unstructured":"Parnes SM. The role of leukotriene inhibitors in allergic rhinitis and paranasal sinusitis. Curr Allergy Asthma Rep. 2002;2:239\u201344.","journal-title":"Curr Allergy Asthma Rep"},{"key":"562_CR15","doi-asserted-by":"publisher","first-page":"109674","DOI":"10.1016\/j.ijporl.2019.109674","volume":"127","author":"N Bayar Muluk","year":"2019","unstructured":"Bayar Muluk N, Bafaqeeh SA, Cingi C. Anti-IgE treatment in allergic rhinitis. Int J Pediatr Otorhinolaryngol. 2019;127:109674.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"562_CR16","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1136\/bmj.1.4813.761","volume":"1","author":"AW Frankland","year":"1953","unstructured":"Frankland AW, Gorrill RH. Summer hay-fever and asthma treated with antihistaminic drugs. Br Med J. 1953;1:761\u20134.","journal-title":"Br Med J"},{"key":"562_CR17","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.anai.2016.06.009","volume":"117","author":"GW Bensch","year":"2016","unstructured":"Bensch GW. Safety of intranasal corticosteroids. Ann Allergy Asthma Immunol. 2016;117:601\u20135.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"562_CR18","first-page":"65","volume":"75","author":"DT Scow","year":"2007","unstructured":"Scow DT, Luttermoser G, Dickerson K. Leukotriene inhibitors in the treatment of allergy and asthma. Am Fam Physician. 2007;75:65\u201370.","journal-title":"Am Fam Physician"},{"key":"562_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000505209","volume":"181","author":"J Zhou","year":"2020","unstructured":"Zhou J, Lu Y, Li F, Wu W, Xie D, Feng Y. In vitro and in vivo antiallergic effects of taurine on allergic rhinitis. Int Arch Allergy Immunol. 2020;181:1\u201313.","journal-title":"Int Arch Allergy Immunol"},{"key":"562_CR20","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.yrtph.2008.01.004","volume":"50","author":"A Shao","year":"2008","unstructured":"Shao A, Hathcock JN. Risk assessment for the amino acids taurine, l-glutamine and l-arginine. Regul Toxicol Pharmacol. 2008;50:376\u201399.","journal-title":"Regul Toxicol Pharmacol"},{"key":"562_CR21","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/ene.14107","volume":"27","author":"L Ding","year":"2020","unstructured":"Ding L, Yang Z, Liu G, Ran N, Yi M, Li H, Zhao H, Tang L, Cheng H, Zhao J, Zhang Y, Ji X, et al. Safety and efficacy of taurine as an add-on treatment for tics in youngsters. Eur J Neurol. 2020;27:490\u20137.","journal-title":"Eur J Neurol"},{"key":"562_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.lfs.2017.07.007","volume":"184","author":"SY Nam","year":"2017","unstructured":"Nam SY, Kim HM, Jeong HJ. The potential protective role of taurine against experimental allergic inflammation. Life Sci. 2017;184:18\u201324.","journal-title":"Life Sci"},{"key":"562_CR23","first-page":"2057","volume":"29","author":"Q Li","year":"2015","unstructured":"Li Q, Chen Y, Ma Y, Zhang Y, Sun C. Role of P-JNK and P-c-Jun of JNK transduction pathway on the nasal mucosa remodeling in allergic rhinitis rats. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2015;29:2057\u20139.","journal-title":"Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"key":"562_CR24","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s11596-010-0218-x","volume":"30","author":"J Liu","year":"2010","unstructured":"Liu J, Liu L, Cui Y, Zhang J, Jiang H. P38 MAPK regulates Th2 cytokines release in PBMCs in allergic rhinitis rats. J Huazhong Univ Sci Technol Med Sci. 2010;30:222\u20135.","journal-title":"J Huazhong Univ Sci Technol Med Sci"},{"key":"562_CR25","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.intimp.2019.03.004","volume":"71","author":"J Yang","year":"2019","unstructured":"Yang J, Zhong W, Xue K, Wang Z. Epigenetic changes: an emerging potential pharmacological target in allergic rhinitis. Int Immunopharmacol. 2019;71:76\u201383.","journal-title":"Int Immunopharmacol"},{"key":"562_CR26","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/ncprheum0624","volume":"3","author":"X Valencia","year":"2007","unstructured":"Valencia X, Lipsky PE. CD4+CD25+FoxP3+ regulatory T cells in autoimmune diseases. Nat Clin Pract Rheumatol. 2007;3:619\u201326.","journal-title":"Nat Clin Pract Rheumatol"},{"key":"562_CR27","first-page":"981","volume":"198","author":"S Hori","year":"2017","unstructured":"Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. J Immunol. 2017;198:981\u20135.","journal-title":"J Immunol"},{"key":"562_CR28","first-page":"986","volume":"198","author":"JD Fontenot","year":"2017","unstructured":"Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. J Immunol. 2017;198:986\u201392.","journal-title":"J Immunol"},{"key":"562_CR29","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/83713","volume":"27","author":"CL Bennett","year":"2001","unstructured":"Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, Kelly TE, Saulsbury FT, Chance PF, Ochs HD. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet. 2001;27:20\u20131.","journal-title":"Nat Genet"},{"key":"562_CR30","doi-asserted-by":"publisher","first-page":"7050","DOI":"10.4049\/jimmunol.179.10.7050","volume":"179","author":"MD Leech","year":"2007","unstructured":"Leech MD, Benson RA, deVries A, Fitch PM, Howie SEM. Resolution of Der p1-induced allergic airway inflammation is dependent on CD4+CD25+Foxp3+ regulatory cells. J Immunol. 2007;179:7050\u20138.","journal-title":"J Immunol"},{"key":"562_CR31","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2500\/ajra.2017.31.4472","volume":"31","author":"C Palmer","year":"2017","unstructured":"Palmer C, Mulligan JK, Smith SE, Atkinson C. The role of regulatory T cells in the regulation of upper airway inflammation. Am J Rhinol Allergy. 2017;31:345\u201351. https:\/\/doi.org\/10.2500\/ajra.2017.31.4472.","journal-title":"Am J Rhinol Allergy"},{"key":"562_CR32","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.clim.2010.03.006","volume":"136","author":"D Han","year":"2010","unstructured":"Han D, Wang C, Lou W, Gu Y, Wang Y, Zhang L. Allergen-specific IL-10-secreting type I T regulatory cells, but not CD4+CD25+Foxp3+ T cells, are decreased in peripheral blood of patients with persistent allergic rhinitis. Clin Immunol. 2010;136:292\u2013301.","journal-title":"Clin Immunol"},{"key":"562_CR33","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3109\/02770903.2012.695418","volume":"49","author":"S Genc","year":"2012","unstructured":"Genc S, Eroglu H, Kucuksezer UC, Aktas-Cetin E, Gelincik A, Ustyol-Aycan E, Buyukozturk S, Deniz G. The decreased CD4+CD25+FoxP3+ T cells in nonstimulated allergic rhinitis patients sensitized to house dust mites. J Asthma. 2012;49:569\u201374. https:\/\/doi.org\/10.3109\/02770903.2012.695418.","journal-title":"J Asthma"},{"key":"562_CR34","doi-asserted-by":"publisher","first-page":"152","DOI":"10.5935\/1808-8694.20140031","volume":"80","author":"X Huang","year":"2014","unstructured":"Huang X, Chen Y, Zhang F, Yang Q, Zhang G. Desequil\u00edbrio imunol\u00f3gico perif\u00e9rico mediado por c\u00e9lulas Th17\/Treg em pacientes com rinite al\u00e9rgica. Braz J Otorhinolaryngol. 2014;80:152\u20135.","journal-title":"Braz J Otorhinolaryngol"},{"key":"562_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-017-00838-4","volume":"8","author":"IM Dambuza","year":"2017","unstructured":"Dambuza IM, He C, Choi JK, Yu CR, Wang R, Mattapallil MJ, Wingfield PT, Caspi RR, Egwuagu CE. IL-12p35 induces expansion of IL-10 and IL-35-expressing regulatory B cells and ameliorates autoimmune disease. Nat Commun. 2017;8:1\u20132.","journal-title":"Nat Commun"},{"key":"562_CR36","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/ni.2227","volume":"13","author":"LW Collison","year":"2012","unstructured":"Collison LW, Delgoffe GM, Guy CS, Vignali KM, Chaturvedi V, Fairweather D, Satoskar AR, Garcia KC, Hunter CA, Drake CG, Murray PJ, Vignali DAA. The composition and signaling of the IL-35 receptor are unconventional. Nat Immunol. 2012;13:290\u20139.","journal-title":"Nat Immunol"},{"key":"562_CR37","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1007\/s00726-011-1047-3","volume":"42","author":"J Miao","year":"2012","unstructured":"Miao J, Zhang J, Zheng L, Yu X, Zhu W, Zou S. Taurine attenuates Streptococcus uberis-induced mastitis in rats by increasing T regulatory cells. Amino Acids. 2012;42:2417\u201328.","journal-title":"Amino Acids"},{"key":"562_CR38","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1152\/ajprenal.00020.2007","volume":"293","author":"J-S Huang","year":"2007","unstructured":"Huang J-S, Chuang L-Y, Guh J-Y, Huang Y-J, Hsu M-S, Huang J-S, Chuang L-Y, Guh J-Y, Huang Y-J. Antioxidants attenuate high glucose-induced hypertrophic growth in renal tubular epithelial cells. Am J Physiol Ren Physiol. 2007;293:1072\u201382.","journal-title":"Am J Physiol Ren Physiol"},{"key":"562_CR39","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.aller.2016.10.007","volume":"45","author":"C Zhao","year":"2017","unstructured":"Zhao C, Yu S, Li J, Xu W, Ge R. Changes in IL-4 and IL-13 expression in allergic-rhinitis treated with hydrogen-rich saline in guinea-pig model. Allergol Immunopathol. 2017;45:350\u20135.","journal-title":"Allergol Immunopathol"},{"key":"562_CR40","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/rr41","volume":"2","author":"S Greenfeder","year":"2001","unstructured":"Greenfeder S, Umland SP, Cuss FM, Chapman RW, Egan RW. Th2 cytokines and asthma. The role of interleukin-5 in allergic eosinophilic disease. Respir Res. 2001;2:71\u20139.","journal-title":"Respir Res"},{"key":"562_CR41","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4049\/jimmunol.1600506","volume":"198","author":"K Kanai","year":"2017","unstructured":"Kanai K, Park A-M, Yoshida H, Tsunoda I, Yoshie O. IL-35 suppresses lipopolysaccharide-induced airway eosinophilia in EBI3-deficient mice. J Immunol. 2017;198:119\u201327.","journal-title":"J Immunol"},{"key":"562_CR42","first-page":"1868","volume":"21","author":"Y-F Lu","year":"2017","unstructured":"Lu Y-F, Zhang Q-Y, Wang L-H, Liu X-Y, Zhang S-X. The protective effects of taurine on experimental autoimmune myocarditis. Eur Rev Med Pharmacol Sci. 2017;21:1868\u201375.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"562_CR43","doi-asserted-by":"publisher","first-page":"e56101","DOI":"10.1371\/journal.pone.0056101","volume":"8","author":"NW Lutz","year":"2013","unstructured":"Lutz NW, Fernandez C, Pellissier JF, Cozzone PJ, B\u00e9raud E. Cerebral biochemical pathways in experimental autoimmune encephalomyelitis and adjuvant arthritis: a comparative metabolomic study. PLoS ONE. 2013;8:e56101.","journal-title":"PLoS ONE"},{"key":"562_CR44","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.humimm.2018.01.005","volume":"79","author":"CM Gambino","year":"2018","unstructured":"Gambino CM, Di Bona D, Aiello A, Carru C, Duro G, Guggino G, Ferrante A, Zinellu A, Caruso C, Candore G, Accardi G. HLA-C1 ligands are associated with increased susceptibility to systemic lupus erythematosus. Hum Immunol. 2018;79:172\u20137.","journal-title":"Hum Immunol"},{"key":"562_CR45","first-page":"213","volume":"23","author":"H-S Lee","year":"2005","unstructured":"Lee H-S, Goh E-K, Wang S-G, Chon K-M, Kim H-K, Roh H-J. Detection of amino acids in human nasal mucosa using microdialysis technique: increased glutamate in allergic rhinitis. Asian Pac J Allergy Immunol. 2005;23:213\u20139.","journal-title":"Asian Pac J Allergy Immunol"},{"key":"562_CR46","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1002\/alr.22438","volume":"9","author":"JM Xue","year":"2019","unstructured":"Xue JM, Ma F, An YF, Suo LM, Geng XR, Song YN, Mo LH, Luo XQ, Zhang XW, liu DB, Zhao CQ, Yang PC. Probiotic extracts ameliorate nasal allergy by inducing interleukin-35-producing dendritic cells in mice. Int Forum Allergy Rhinol. 2019;9:1289\u201396.","journal-title":"Int Forum Allergy Rhinol"},{"key":"562_CR47","doi-asserted-by":"publisher","first-page":"108383","DOI":"10.1016\/j.clim.2020.108383","volume":"214","author":"G Ruan","year":"2020","unstructured":"Ruan G, Wen X, Yuan Z. Correlation between miR-223 and IL-35 and their regulatory effect in children with allergic rhinitis. Clin Immunol. 2020;214:108383.","journal-title":"Clin Immunol"},{"key":"562_CR48","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.alit.2016.08.014","volume":"66","author":"M Suzuki","year":"2017","unstructured":"Suzuki M, Yokota M, Nakamura Y, Ozaki S, Murakami S. Intranasal administration of IL-35 inhibits allergic responses and symptoms in mice with allergic rhinitis. Allergol Int. 2017;66:351\u20136.","journal-title":"Allergol Int"},{"key":"562_CR49","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2500\/ajr.2007.21.2970","volume":"21","author":"H Hattori","year":"2007","unstructured":"Hattori H, Rosas LE, Okano M, Durbin JE, Nishizaki K, Satoskar AR. STAT1 is involved in the pathogenesis of murine allergic rhinitis. Am J Rhinol. 2007;21:241\u20137.","journal-title":"Am J Rhinol"},{"key":"562_CR50","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1084\/jem.20062129","volume":"204","author":"T Bopp","year":"2007","unstructured":"Bopp T, Becker C, Klein M, Klein-He\u00dfling S, Palmetshofer A, Serfling E, Heib V, Becker M, Kubach J, Schmitt S, Stoll S, Schild H, et al. Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J Exp Med. 2007;204:1303\u201310.","journal-title":"J Exp Med"},{"key":"562_CR51","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1002\/eji.200838603","volume":"39","author":"DK Sojka","year":"2009","unstructured":"Sojka DK, Hughson A, Fowell DJ. CTLA-4 is required by CD4+CD25+ treg to control CD4+ T-cell lymphopenia-induced proliferation. Eur J Immunol. 2009;39:1544\u201351.","journal-title":"Eur J Immunol"},{"key":"562_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-31757-z","volume":"8","author":"S Rosskopf","year":"2018","unstructured":"Rosskopf S, Jahn-Schmid B, Schmetterer KG, Zlabinger GJ, Steinberger P. PD-1 has a unique capacity to inhibit allergen-specific human CD4+ T cell responses. Sci Rep. 2018;8:1\u201311.","journal-title":"Sci Rep"},{"key":"562_CR53","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","volume":"30","author":"M Miyara","year":"2009","unstructured":"Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, Niwa A, Parizot C, Taflin C, Heike T, Valeyre D, Mathian A, Nakahata T, et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity. 2009;30:899\u2013911.","journal-title":"Immunity"}],"container-title":["Allergy, Asthma &amp; Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-021-00562-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13223-021-00562-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-021-00562-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T22:05:41Z","timestamp":1675548341000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacijournal.biomedcentral.com\/articles\/10.1186\/s13223-021-00562-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,19]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["562"],"URL":"https:\/\/doi.org\/10.1186\/s13223-021-00562-1","relation":{},"ISSN":["1710-1492"],"issn-type":[{"value":"1710-1492","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,19]]},"assertion":[{"value":"19 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the independent ethics committee of Dahua Hospital, Shanghai, China and strictly obeyed the Declaration of Helsinki. The experimental procedures were approved by the ethical committee of the Dahua Hospital, Shanghai, China. The handling of mice and all animal experiments were performed according to the Institutional Animal Care and Use Committee (IACUC) guidelines and the institute\u2019s guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"59"}}